Identification of drug metabolites in human plasma or serum integrating metabolite prediction, LC–HRMS and untargeted data processing
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of drug metabolites in human plasma or serum integrating metabolite prediction, LC–HRMS and untargeted data processing
Authors
Keywords
-
Journal
Bioanalysis
Volume 5, Issue 17, Pages 2115-2128
Publisher
Future Science, LTD
Online
2013-08-21
DOI
10.4155/bio.13.178
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Automatic Chemical Structure Annotation of an LC–MSn Based Metabolic Profile from Green Tea
- (2013) Lars Ridder et al. ANALYTICAL CHEMISTRY
- Importance of highly selective LC–MS/MS analysis for the accurate quantification of tamoxifen and its metabolites: focus on endoxifen and 4-hydroxytamoxifen
- (2012) N. G. L. Jager et al. BREAST CANCER RESEARCH AND TREATMENT
- Progressing preclinical drug candidates: strategies on preclinical safety studies and the quest for adequate exposure
- (2012) John Higgins et al. DRUG DISCOVERY TODAY
- Computational Prediction of Metabolism: Sites, Products, SAR, P450 Enzyme Dynamics, and Mechanisms
- (2012) Johannes Kirchmair et al. Journal of Chemical Information and Modeling
- Substructure-based annotation of high-resolution multistage MSnspectral trees
- (2012) Lars Ridder et al. RAPID COMMUNICATIONS IN MASS SPECTROMETRY
- Use of relative 12C/14C isotope ratios to estimate metabolite concentrations in the absence of authentic standards
- (2012) Filip Cuyckens et al. Bioanalysis
- Analytical Strategies for Assessment of Human Metabolites in Preclinical Safety Testing
- (2011) Shuguang Ma et al. ANALYTICAL CHEMISTRY
- Tamoxifen Metabolite Concentrations, CYP2D6 Genotype, and Breast Cancer Outcomes
- (2011) L Madlensky et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Metabolism and Disposition of [14C]Brivanib Alaninate after Oral Administration to Rats, Monkeys, and Humans
- (2011) J. Gong et al. DRUG METABOLISM AND DISPOSITION
- Evaluation of relative LC/MS response of metabolites to parent drug in LC/nanospray ionization mass spectrometry: potential implications in MIST assessment
- (2011) Simone Schadt et al. JOURNAL OF MASS SPECTROMETRY
- Investigational study of tamoxifen phase I metabolites using chromatographic and spectroscopic analytical techniques
- (2011) S.F. Teunissen et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Radiolabelled mass-balance excretion and metabolism studies in laboratory animals: are they still necessary?
- (2011) R. Scott Obach et al. XENOBIOTICA
- Bioanalytical methods for determination of tamoxifen and its phase I metabolites: A review
- (2010) S.F. Teunissen et al. ANALYTICA CHIMICA ACTA
- Metabolism, Excretion, and Pharmacokinetics of [14C]INCB018424, a Selective Janus Tyrosine Kinase 1/2 Inhibitor, in Humans
- (2010) A. D. Shilling et al. DRUG METABOLISM AND DISPOSITION
- Disposition of [1'-14C]Stavudine after Oral Administration to Humans
- (2010) L. Zhou et al. DRUG METABOLISM AND DISPOSITION
- Metabolism and Disposition of [14C]BMS-690514, an ErbB/Vascular Endothelial Growth Factor Receptor Inhibitor, after Oral Administration to Humans
- (2010) L. J. Christopher et al. DRUG METABOLISM AND DISPOSITION
- Metabolism and Disposition of 14C-Labeled Peliglitazar in Humans
- (2010) L. Wang et al. DRUG METABOLISM AND DISPOSITION
- Disposition and Metabolism of [14C]SB-649868, an Orexin 1 and 2 Receptor Antagonist, in Humans
- (2010) C. Renzulli et al. DRUG METABOLISM AND DISPOSITION
- Excretion and Metabolism of Lersivirine (5- benzene-1,3-dicarbonitrile), a Next-Generation Non-Nucleoside Reverse Transcriptase Inhibitor, after Administration of [14C]Lersivirine to Healthy Volunteers
- (2010) M. Vourvahis et al. DRUG METABOLISM AND DISPOSITION
- Metabolite identification by liquid chromatography-mass spectrometry
- (2010) Bhagwat Prasad et al. TRAC-TRENDS IN ANALYTICAL CHEMISTRY
- A radiocalibration method with pseudo internal standard to estimate circulating metabolite concentrations
- (2010) Ping Yi et al. Bioanalysis
- A Holistic Strategy for Characterizing the Safety of Metabolites through Drug Discovery and Development
- (2009) Don Walker et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Identification of a Novel N-Carbamoyl Glucuronide: In Vitro, In Vivo, and Mechanistic Studies
- (2009) M. Gunduz et al. DRUG METABOLISM AND DISPOSITION
- Metabolic Disposition of [14C]Bazedoxifene in Healthy Postmenopausal Women
- (2009) A. Chandrasekaran et al. DRUG METABOLISM AND DISPOSITION
- Comparative Metabolism of 14C-Labeled Apixaban in Mice, Rats, Rabbits, Dogs, and Humans
- (2009) D. Zhang et al. DRUG METABOLISM AND DISPOSITION
- In silicomethods for predicting metabolism and mass fragmentation applied to quetiapine in liquid chromatography/time-of-flight mass spectrometry urine drug screening
- (2009) Anna Pelander et al. RAPID COMMUNICATIONS IN MASS SPECTROMETRY
- Metabolites in safety testing
- (2009) Timothy W Robison et al. Bioanalysis
- SyGMa: Combining Expert Knowledge and Empirical Scoring in the Prediction of Metabolites
- (2008) Lars Ridder et al. ChemMedChem
- Absorption, Metabolism, and Excretion of [14C]Vildagliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, in Humans
- (2008) H. He et al. DRUG METABOLISM AND DISPOSITION
- Metabolic Soft Spot Identification and Compound Optimization in Early Discovery Phases Using MetaSite and LC-MS/MS Validation
- (2008) Markus Trunzer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Idiosyncratic Drug Reactions: Past, Present, and Future
- (2007) Jack Uetrecht CHEMICAL RESEARCH IN TOXICOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now